[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Robert Gilliland [@WealthWithRG](/creator/twitter/WealthWithRG) on x 5218 followers Created: 2025-07-23 20:32:53 UTC $AVXL peer reviewed JPAD article endorsed by XX Alzheimer authorities reports excellent data with even stronger long-term OLE results. Non-cancer candidates at this stage carry over XX % EMA approval odds. Experts value a European approval at $XX B and a U S approval at $XX B, while the current market cap sits near $X B. Do the math. XXX engagements  **Related Topics** [market cap](/topic/market-cap) [ole](/topic/ole) [longterm](/topic/longterm) [$avxl](/topic/$avxl) [Post Link](https://x.com/WealthWithRG/status/1948119146002329767)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Robert Gilliland @WealthWithRG on x 5218 followers
Created: 2025-07-23 20:32:53 UTC
$AVXL peer reviewed JPAD article endorsed by XX Alzheimer authorities reports excellent data with even stronger long-term OLE results.
Non-cancer candidates at this stage carry over XX % EMA approval odds.
Experts value a European approval at $XX B and a U S approval at $XX B, while the current market cap sits near $X B.
Do the math.
XXX engagements
Related Topics market cap ole longterm $avxl
/post/tweet::1948119146002329767